Before this decision by the European Medicines Agency, deaths among children in 2021 were below the expected rate. But following the emergency use authorisation, we discovered that excess deaths among children had risen by a deeply troubling 1,599% by the end of the year compared to the 2017 to 2020 average.
Now, three weeks after our investigation, EuroMOMO, which provides the statistics, has been forced to officially acknowledge the elevated excess mortality among children and has opened a Europe-wide investigation into the possible causes.
We conducted our investigation using the data published by EuroMOMO in their week 33, 2022 bulletin.
Here’s a snapshot of the bulletin published by EuroMOMO at the time –
Upon realising that we have forced EuroMOMO to finally investigate why so many children are dying across Europe, we decided to revisit the official published data to find out how many more children had died between week 33 and week 36. But to our surprise and disgust, we discovered that EuroMOMO has now altered the baseline meaning all data on excess deaths from 2017 through to 2022 has been altered since our week 33 investigation.
The following is a snapshot of the data made available by EuroMOMO in week 36, and it shows 545 excess deaths among children aged 0 to 14 up to week 36 in 2022.
No comments:
Post a Comment